RESUMEN
Objective: Evolving research links human rhinovirus (HRV) with status asthmaticus (SA) as well as severe respiratory illness in patients with atopy and asthma. This case series reviews five episodes of HRV-associated SA that required extracorporeal membrane oxygenation (ECMO). Methods: Charts of four patients, five total episodes of ECMO, with SA secondary to HRV were reviewed in this IRB-approved case series. Outcomes included demographic information, past medical history, clinical parameters and spirometry. Results: Patients (three male, one female), mean age 9 years (range 7-12 years) at the time of admission, were African American, on Medicaid, carried a diagnosis of persistent asthma, and had documented non-adherence to prescribed, daily controller medications. One patient had passive smoke exposure. All patients had a mean IgE of 734 (range 12-2497) with seasonal allergic rhinitis was diagnosed in three patients. Cases occurred in spring (3/5) and fall (2/5). Venous/venous ECMO (4/5) or venous/arterial ECMO (1/5) was continued for a mean duration of 4.2 days (range 3-7 days). Spirometry after hospitalization had a mean FEV1 of 1.59 L (81% predicted, range 69%-91%), and an FEF25%-75% 1.13 L (47.5% predicted, range 41%-65%) at an average of 16.7 weeks post ECMO. Conclusions: This case series highlights the association between persistent, poorly controlled asthma and severe SA with HRV infection resulting in ECMO. Despite life-threatening illness, these patients did not demonstrate significant large-airway obstruction following infection. However, patients showed persistently abnormal small airway function, which could be a risk factor or early evidence of vulnerability to infection.
Asunto(s)
Oxigenación por Membrana Extracorpórea , Infecciones por Picornaviridae/complicaciones , Rhinovirus/inmunología , Estado Asmático/terapia , Adolescente , Niño , Femenino , Humanos , Inmunoglobulina E/sangre , Inmunoglobulina E/inmunología , Masculino , Infecciones por Picornaviridae/inmunología , Infecciones por Picornaviridae/terapia , Infecciones por Picornaviridae/virología , Estudios Retrospectivos , Rhinovirus/aislamiento & purificación , Estado Asmático/sangre , Estado Asmático/inmunología , Brote de los SíntomasRESUMEN
BACKGROUND: Children with status asthmaticus (SA) often present with fever and are evaluated with chest radiographs (CXRs). In the absence of a confirmatory test for bacterial infection, antibiotics are started whenever there are radiological infiltrates or if there is a suspicion of pneumonia. We undertook this study to determine if serum procalcitonin (PCT) levels at admission are altered in critically ill children with SA. We also sought to determine if serum PCT levels are elevated in children with radiological infiltrates or in children who were treated with antibiotics. METHODS: This is a prospective single-center observational study evaluating serum PCT levels in critically ill children with SA. Study subjects included children 1 to 21 years old, admitted to a pediatric intensive care unit (PICU) with SA between March 2012 and April 2013. For the purposes of this study, patients whose CXRs were read by the radiologist as probable bacterial pneumonia was defined as having "radiological bacterial pneumonia," whereas patients who received antibiotics by the treating physician were defined as having "clinician-diagnosed pneumonia." RESULTS: Sixty-one patients with a median age of 7.3 years (interquartile range, 4-10 years) were included in the study. Fifty-one percent were male. Average Pediatric Risk of Mortality III score was 2.7 (SD, 2.9). Three patients (5%) were determined to have radiological bacterial pneumonia, whereas 52 (85%) did not. Six patients (10%) were indeterminate. The mean PCT level for all patients was 0.65 (SD, 1.54) ng/mL, whereas the median PCT level was 0.3 ng/mL. There was no significant difference in the mean PCT levels between the patients with and without clinician-diagnosed pneumonia (0.33 [SD, 0.36] vs 0.69 [SD, 1.67], P = 0.44). Using a PCT cutoff level of 0.5 ng/mL, a significant association was found with the presence of fever (P = 0.004), but no significant association was found with the presence of CXR infiltrates, radiological bacterial pneumonia, hospital length of stay, PICU length of stay, Pediatric Risk of Mortality III scores, or receipt of antibiotics. CONCLUSIONS: Serum PCT level was not elevated to greater than 0.5 ng/mL in 75% of this cohort of critically ill children with SA admitted to PICU. Presence of CXR infiltrates was not associated with higher PCT levels. Large clinical trials are needed to study the diagnostic and predictive role of PCT in this patient population.
Asunto(s)
Enfermedad Crítica/epidemiología , Neumonía Bacteriana/diagnóstico por imagen , Polipéptido alfa Relacionado con Calcitonina/sangre , Estado Asmático/epidemiología , Adolescente , Niño , Preescolar , Estudios de Cohortes , Enfermedad Crítica/mortalidad , Femenino , Humanos , Lactante , Unidades de Cuidado Intensivo Pediátrico/estadística & datos numéricos , Tiempo de Internación/estadística & datos numéricos , Masculino , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/epidemiología , Estudios Prospectivos , Estado Asmático/sangre , Adulto JovenRESUMEN
The aim of the study - low circulating vitamin D level maybe related to poor asthma control status and decreased lung function. The aim of our research is to establish correlation between serum vitamin D level, asthma control status and lung function. The study was performed in children aged 6-15 years old, including patients with asthma (n=50), who referred to Sachkhere medical center for a visit. The status of asthma control in the basic group was classified as controlled (n=31) and uncontrolled (n=19). The children underwent serum vitamin D and IgE level, spirometry and skin prick tests for the study. Using the multivariate logistic regression analysis, the presence of asthma was associated with the reduced level of vitamin D (ORâ =â 1.35, 95% CI (1,14-1.58) Pâ =â 0.011; χ2=6.78; F-0.022) in children with uncontrolled bronchial asthma. 48% of the patients in the group- controlled asthma (n=15) had vitamin D deficit, and in 52% of the cases (n=16) was confirmed with vitamin D insufficient. In the group -uncontrolled asthma - 5% of the patients (n=1) had Vitamin D insufficiency in blood serum. In 95% (n=18) of the patients vitamin D level was significantly low <20 ng/ml. According the results, decreased pulmonary function (p-0.039; χ2-3.12) is strongly associated with low level of vitamin D; but neither serum IgE level (p-0.54; χ2-10.9), nor skin prick test result on dust mite (p-0.50, χ2-5.12 ) was correlations with serum vitamin D low level. The presence of vitamin D deficiency effectively predict increased risk of uncontrolled bronchial asthma in children. Serum vitamin D level is related to lung function too. Therefore, the normalization of the serum levels of Vitamin D may have beneficial effect on improvement of asthma control in the complex of asthma management and preventive measures.
Asunto(s)
Asma/sangre , Deficiencia de Vitamina D/sangre , Vitamina D/sangre , Adolescente , Antiasmáticos/administración & dosificación , Asma/tratamiento farmacológico , Asma/inmunología , Niño , Femenino , Humanos , Inmunoglobulina E/sangre , Modelos Logísticos , Masculino , Pruebas Cutáneas , Espirometría , Estado Asmático/sangreRESUMEN
INTRODUCTION: Status asthmaticus is a life-threatening condition characterized by progressive respiratory failure due to asthma that is unresponsive to standard therapeutic measures. We used extracorporeal membrane oxygenation (ECMO) to treat patients with near-fatal status asthamticus who did not respond to aggressive medical therapies and mechanical ventilation under controlled permissive hypercapnia. MATERIALS AND METHODS: Between January 2011 and October 2015, we treated 16 adult patients with status asthmaticus (8 women, 8 men, mean age: 50.5±10.6years) with veno-venous ECMO (13 patients) or veno-arterial (3 patients). Patients failed to respond to conventional therapies despite receiving the most aggressive therapies, including maximal medical treatments, mechanical ventilation under controlled permissive hypercapnia and general anesthetics. RESULTS: Mean time spent on ECMO was 300±11.8 hours (range 36-384 hours). PaO2, PaCO2 and pH showed significant improvement promptly after ECMO initiation p=0.014, 0.001 and <0.001, respectively, and such values remained significantly improved after ECMO, p=0.004 and 0.001 and <0.001, respectively. The mean time of ventilation after decannulation until extubation was 175±145.66 hours and the median time to intensive care unit discharge after decannulation was 234±110.30 hours. All 16 patients survived without neurological sequelae. CONCLUSIONS: ECMO could provide adjunctive pulmonary support for intubated asthmatic patients who remain severely acidotic and hypercarbic despite aggressive conventional therapy. ECMO should be considered as an early treatment in patients with status asthmaticus whose gas exchange cannot be satisfactorily maintained by conventional therapy for providing adequate gas change and preventing lung injury from the ventilation.
Asunto(s)
Oxigenación por Membrana Extracorpórea/métodos , Estado Asmático/terapia , Enfermedad Aguda , Adulto , Dióxido de Carbono/sangre , Diseño de Equipo , Oxigenación por Membrana Extracorpórea/instrumentación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Estado Asmático/sangreRESUMEN
OBJECTIVES: Tachycardia and diastolic hypotension have been associated with ß-2 agonist use. In the setting of ß-agonist-induced chronotropy and inotropy, diastolic hypotension may limit myocardial blood flow. We hypothesized that diastolic hypotension is associated with ß-agonist use and that diastolic hypotension and tachycardia are associated with biochemical evidence of myocardial injury in children with asthma. DESIGN: Two patient cohorts were collected. The first, consisting of patients transported for respiratory distress having received at least 10 mg of albuterol, was studied for development of tachycardia and hypotension. The second, consisting of patients who had troponin measured during treatment for status asthmaticus with continuous albuterol, was studied for factors associated with elevated troponin. Exclusion criteria for both cohorts included age younger than 2 years old, sepsis, pneumothorax, cardiac disease, and antihypertensive use. Albuterol dose, other medications, and vital signs were collected. Diastolic and systolic hypotension were defined as an average value below the fifth percentile for age and tachycardia as average heart rate above the 98th percentile for age. PATIENTS: Ninety of 1,390 children transported for respiratory distress and 64 of 767 children with status asthmaticus met inclusion criteria. MEASUREMENTS AND MAIN RESULTS: Diastolic hypotension occurred in 56% and 98% of the first and second cohorts, respectively; tachycardia occurred in 94% and 95% of the first and second cohorts, respectively. Diastolic hypotension and tachycardia had a weak linear correlation with albuterol dose (p = 0.02 and p = 0.005, respectively). Thirty-six percent had troponin > 0.1 ng/mL (range, 0-12.6). In multivariate analysis, interaction between diastolic hypotension and tachycardia alone was associated with elevated troponin (p = 0.02). CONCLUSIONS: Diastolic hypotension and tachycardia are dose-dependent side effects of high-dose albuterol. In high-risk patients with status asthmaticus treated with albuterol, diastolic hypotension and tachycardia are associated with biochemical evidence of myocardial injury. Diastolic hypotension, especially combined with tachycardia, could be a reversible risk factor for myocardial injury related to ß-agonist use.
Asunto(s)
Agonistas de Receptores Adrenérgicos beta 2/efectos adversos , Albuterol/efectos adversos , Hipotensión/inducido químicamente , Isquemia Miocárdica/etiología , Estado Asmático/tratamiento farmacológico , Taquicardia/inducido químicamente , Agonistas de Receptores Adrenérgicos beta 2/uso terapéutico , Albuterol/uso terapéutico , Biomarcadores/sangre , Niño , Preescolar , Estudios de Cohortes , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Electrocardiografía , Humanos , Hipotensión/sangre , Hipotensión/complicaciones , Modelos Lineales , Modelos Logísticos , Isquemia Miocárdica/sangre , Isquemia Miocárdica/diagnóstico , Estudios Retrospectivos , Factores de Riesgo , Estado Asmático/sangre , Estado Asmático/complicaciones , Taquicardia/sangre , Taquicardia/complicaciones , Resultado del Tratamiento , Troponina I/sangreRESUMEN
OBJECTIVES: The study's objectives were to evaluate serial troponin concentrations as a marker of cardiac toxicity in children receiving intravenous terbutaline for status asthmaticus and to study if troponin concentrations are affected by severity of asthma and risk factors for severe asthma. METHODS: This was a prospective observational study in 20 consecutive patients who were admitted to a tertiary care pediatric intensive care unit for status asthmaticus and received intravenous terbutaline. Cardiac troponin I (cTnI) concentrations were measured half an hour before the bolus of intravenous terbutaline, 4 hours after terbutaline, and then every 24 hours until discontinuation of the continuous terbutaline infusion. RESULTS: Ten patients had cTnI concentrations greater than 0.03 ng/mL. Maximum cTnI concentrations were recorded after the terbutaline bolus in 6 patients, during terbutaline infusion in 3 patients, and before terbutaline use in 1 patient. Three of these 10 (3/10) patients showed increased cTnI concentrations before the terbutaline bolus. One patient had a significant elevation in cTnI concentration (peak level of 3.79 ng/mL) with electrocardiogram (ECG) changes of myocardial injury that normalized upon discontinuation of terbutaline. All other patients with elevated cTnI concentrations had normal ECG findings. CONCLUSIONS: Elevated cTnI concentrations were observed in 50% of patients treated with intravenous terbutaline for status asthmaticus. Clinically significant cardiotoxicity was not observed except in 1 patient in whom the abnormal ECG findings normalized upon discontinuation of terbutaline. There was no statistically significant difference in asthma severity or in the risk factors for severe asthma in children with and without elevation of cTnI concentrations.
Asunto(s)
Broncodilatadores/administración & dosificación , Corazón/efectos de los fármacos , Estado Asmático/tratamiento farmacológico , Terbutalina/administración & dosificación , Troponina/sangre , Humanos , Infusiones Intravenosas , Factores de Riesgo , Estado Asmático/sangreRESUMEN
OBJECTIVE: To investigate plasma glutathione peroxidase concentration, glutathione peroxidase activity, plasma selenium and oxidative stress in acute severe asthma. MATERIAL AND METHODS: The study was case-control in design, with cases presenting to the emergency department with acute severe asthma and controls randomly selected from a larger cross-sectional study. Plasma malondialdehyde (MDA) was used as a measure of oxidative stress and plasma selenium was measured using ICP-MS. Glutathione peroxidase (GPx) activity was analysed using a colorimetric GPx assay and plasma GPx level was measured by enzyme-linked immunosorbent assay (ELISA). RESULTS: Fifteen cases [mean (range) predicted peak expiratory flow rate (PEFR) of 43% (20-69)] and 15 matched controls were recruited. MDA levels (mean+/-SD) were higher in acute asthma subjects (1.30+/-0.56 micromol/L) than in controls (0.86+/-0.53 micromol/L; p<0.05). There were no differences between cases and controls for selenium (99+/-34 microg/L versus 109+/-17 microg/L) or for GPx activity (39+/-25 nmol min(-1) mL(-1) versus 38+/-24 nmol min(-1) mL(-1)), however, GPx plasma levels measured by ELISA were higher in cases than controls (22.5+/-10.8 mg/L versus 13.8+/-7.3 mg/L; p<0.05). CONCLUSIONS: Patients with acute severe asthma demonstrated increased MDA levels but no differences in plasma selenium levels or GPx activity. GPx levels measured by ELISA were elevated in severe asthma. These results are consistent with an adaptive up-regulation of GPx to protect against oxidative stress.
Asunto(s)
Asma/sangre , Glutatión Peroxidasa/sangre , Malondialdehído/sangre , Selenio/sangre , Adolescente , Adulto , Anciano , Asma/fisiopatología , Estudios de Casos y Controles , Cromatografía Líquida de Alta Presión , Femenino , Humanos , Masculino , Espectrometría de Masas/métodos , Persona de Mediana Edad , Estrés Oxidativo , Valores de Referencia , Estado Asmático/sangre , Regulación hacia ArribaRESUMEN
BACKGROUND: Near-fatal asthma (NFA) is characterized by severe asthma attacks usually requiring intensive care unit admission. This phenotype of asthma has been studied mainly in acute conditions. METHODS: The aim of our study was to compare the clinical, functional and inflammatory characteristics of NFA patients with mild to severe asthmatics in stable conditions. We recruited 155 asthmatic patients from five centres of the European Network for Understanding Mechanisms of Severe Asthma: 67 patients with mild-to-moderate asthma controlled by low/medium doses of inhaled corticosteroids; 64 with severe asthma that, despite treatment with high doses of inhaled corticosteroids, long-acting beta2-agonists and for 1/3 also with regular oral corticosteroids, had at least one asthma exacerbation in the previous year; 24 with an NFA episode in the previous 5 years in the absence of inclusion criteria for the previous groups. All the patients were examined in stable conditions. RESULTS: NFA patients were taking less corticosteroids and were less compliant to prescribed asthma medications than the other two groups of patients. Lung function, blood gases, atopic status, sputum and blood inflammatory cell count of NFA patients were similar to mild-to-moderate, but not severe, asthmatic patients. CONCLUSIONS: In stable conditions patients with an NFA attack in the previous 5 years cannot be distinguished from patients with mild-to-moderate asthma, while they are different from severe asthmatics both in terms of lung function and of airway inflammation. The risk factor that characterizes this group of patients is reduced usage of prophylactic corticosteroids.
Asunto(s)
Estado Asmático/etiología , Adulto , Antiasmáticos/administración & dosificación , Asma/sangre , Asma/tratamiento farmacológico , Asma/fisiopatología , Estudios de Cohortes , Esquema de Medicación , Femenino , Volumen Espiratorio Forzado , Glucocorticoides/administración & dosificación , Humanos , Hipersensibilidad Inmediata/complicaciones , Recuento de Leucocitos , Masculino , Persona de Mediana Edad , Oxígeno/sangre , Presión Parcial , Cooperación del Paciente , Fenotipo , Factores de Riesgo , Índice de Severidad de la Enfermedad , Pruebas Cutáneas , Estado Asmático/sangre , Estado Asmático/fisiopatología , Estado Asmático/prevención & control , Capacidad VitalRESUMEN
OBJECTIVES: To assess the effect of administration of sodium bicarbonate on carbon dioxide levels in children with life-threatening asthma (LTA) and to evaluate the clinical effect of this treatment. STUDY DESIGN: Retrospective study. SETTING: A pediatric ICU (PICU) of a tertiary care university hospital. PATIENTS: Seventeen children with LTA who received sodium bicarbonate. MEASUREMENTS AND RESULTS: In January 1999, a new protocol for the treatment of LTA was initiated in our institution, incorporating the use of IV sodium bicarbonate in acidotic patients (pH < 7.15) with refractory status asthmaticus. Since January 1999, sodium bicarbonate was administered to 17 patients; 5 patients received two or three doses of sodium bicarbonate. In three patients, sodium bicarbonate was administered after intubation. Intubation and mechanical ventilation were performed in five patients before admission to the PICU, and in one patient during admission. There was a significant decrease of Pco(2) after sodium bicarbonate infusion (p = 0.007). An improvement of respiratory distress in all but one patient was seen as well. CONCLUSIONS: Administration of sodium bicarbonate in 17 children with LTA was associated with a significant decrease in Pco(2) and an improvement of respiratory distress. The possible benefits of sodium bicarbonate in LTA deserve further study in a controlled, prospective design.
Asunto(s)
Acidosis/tratamiento farmacológico , Dióxido de Carbono/sangre , Bicarbonato de Sodio/administración & dosificación , Estado Asmático/sangre , Acidosis/etiología , Adolescente , Niño , Femenino , Humanos , Infusiones Intravenosas , Intubación Intratraqueal , Masculino , Respiración Artificial , Estado Asmático/complicaciones , Estado Asmático/fisiopatología , Estado Asmático/terapiaRESUMEN
OBJECTIVE: Acute asphyxial asthma (AAA) is well described in adult patients and is characterized by a sudden onset that may rapidly progress to a near-arrest state. Despite the initial severity of AAA, mechanical ventilation often restores gas exchange promptly, resulting in shorter durations of ventilation. We believe that AAA can occur in children and can lead to respiratory failure that requires mechanical ventilation. Furthermore, children with rapid-onset respiratory failure that requires intubation in the emergency department (ED) are more likely to have AAA and a shorter duration of mechanical ventilation than those intubated in the pediatric intensive care unit (PICU). METHODS: An 11-year retrospective chart review (1991-2002) was conducted of all children who were aged 2 through 18 years and had the primary diagnosis of status asthmaticus and required mechanical ventilation. RESULTS: During the study period, 33 (11.4%) of 290 PICU admissions for status asthmaticus required mechanical ventilation. Thirteen children presented with rapid respiratory failure en route, on arrival, or within 30 minutes of arrival to the ED versus 20 children who progressed to respiratory failure later in their ED course or in the PICU. Mean duration of mechanical ventilation was significantly shorter in the children who presented with rapid respiratory failure versus those with progressive respiratory failure (29 +/- 43 hours vs 88 +/- 72 hours). Children with rapid respiratory failure had greater improvements in ventilation and oxygenation than those with progressive respiratory failure as measured by pre- and postintubation changes in arterial carbon dioxide pressure, arterial oxygen pressure/fraction of inspired oxygen ratio, and alveolar-arterial gradient. According to site of intubation, 23 children required intubation in the ED, whereas 10 were intubated later in the PICU. Mean duration of mechanical ventilation was significantly shorter in the ED group versus the PICU group (42 +/- 63 hours vs 118 +/- 46 hours). There were significantly greater improvements in ventilation and oxygenation in the ED group versus the PICU group as measured by pre- and postintubation changes in arterial carbon dioxide pressure and arterial oxygen pressure/fraction of inspired oxygen ratio. CONCLUSIONS: AAA occurs in children and shares characteristics seen in adult counterparts. Need for early intubation is a marker for AAA and may not represent a failure to maximize preintubation therapies. AAA represents a distinct form of life-threatening asthma and requires additional study in children.
Asunto(s)
Asfixia/etiología , Respiración Artificial , Insuficiencia Respiratoria/terapia , Estado Asmático/complicaciones , Estado Asmático/terapia , Adolescente , Asfixia/terapia , Dióxido de Carbono/sangre , Niño , Preescolar , Femenino , Humanos , Masculino , Oxígeno/sangre , Insuficiencia Respiratoria/etiología , Estudios Retrospectivos , Estado Asmático/sangre , Factores de TiempoRESUMEN
OBJECTIVE: The optimum strategy for mechanical ventilation in a child with status asthmaticus is not established. Volume-controlled ventilation continues to be the traditional approach in such children. Pressure-controlled ventilation may be theoretically more advantageous in allowing for more uniform ventilation. We describe our experience with pressure-controlled ventilation in children with severe respiratory failure from status asthmaticus. DESIGN: Retrospective review. SETTING: Pediatric intensive care unit in a university-affiliated children's hospital. PATIENTS: All patients who received mechanical ventilation for status asthmaticus. INTERVENTIONS: Pressure-controlled ventilation was used as the initial ventilatory strategy. The optimum pressure control, rate, and inspiratory and expiratory time were determined based on blood gas values, flow waveform, and exhaled tidal volume. MEASUREMENT AND MAIN RESULTS: Forty patients were admitted for 51 episodes of severe status asthmaticus requiring mechanical ventilation. Before the institution of pressure-controlled ventilation, median pH and Pco(2) were 7.21 (range, 6.65-7.39) and 65 torr (29-264 torr), respectively. Four hours after pressure-controlled ventilation, median pH increased to 7.31 (6.98-7.45, p <.005), and Pco(2) decreased to 41 torr (21-118 torr, p <.005). For patients with respiratory acidosis (Pco(2) >45 torr) within 1 hr of starting pressure-controlled ventilation, the median length of time until Pco(2) decreased to <45 torr was 5 hrs (1-51 hrs). Oxygen saturation was maintained >95% in all patients. Two patients had pneumomediastinum before pressure-controlled ventilation. One patient each developed pneumothorax and subcutaneous emphysema after initiation of pressure-controlled ventilation. All patients survived without any neurologic morbidity. Median duration of mechanical ventilation was 29 hrs (4-107 hrs), intensive care stay was 56 hrs (17-183 hrs), and hospitalization was 5 days (2-20 days). CONCLUSIONS: Based on this retrospective study, we suggest that pressure-controlled ventilation is an effective ventilatory strategy in severe status asthmaticus in children. Pressure-controlled ventilation represents a therapeutic option in the management of such children.
Asunto(s)
Respiración con Presión Positiva , Estado Asmático/terapia , Acidosis Respiratoria/etiología , Acidosis Respiratoria/terapia , Adolescente , Análisis de los Gases de la Sangre , Niño , Preescolar , Femenino , Humanos , Lactante , Unidades de Cuidado Intensivo Pediátrico , Masculino , Estudios Retrospectivos , Estado Asmático/sangre , Estado Asmático/complicaciones , Volumen de Ventilación PulmonarRESUMEN
OBJECTIVE: Salbutamol is commonly delivered as a racemic mixture of pharmacologically active (R)-salbutamol and inactive (S)-salbutamol. This study investigated inactive (S)- and active (R)-salbutamol plasma levels and their relationship to dose in patients with severe asthma. METHODS: Basic demographics, racemic-salbutamol dose in the preceding 24 h, lung function tests at baseline and 1 h, and a 10 mL plasma sample were obtained from subjects presenting to the Department of Emergency Medicine with acute asthma. Plasma determinations were carried out using an LC-MS assay with solid phase extraction. RESULTS: All patients (n = 5) had detectable levels of drug in plasma with range of 0.9-7.7 and 4.7-27.4 ng/mL for (R)-salbutamol and (S)-salbutamol respectively. These were correlated to total racemic salbutamol dose. The range of the (S) : (R) ratio was 2.0-5.2, with (R)-salbutamol representing 16-33% of the total plasma concentration, which did not correlate with total salbutamol dose. CONCLUSION: Only a small fraction of total plasma salbutamol concentration was found to consist of active enantiomer in patients with an acute severe exacerbation of asthma actively undergoing treatment with racemic-salbutamol. As a result of the possible contribution of (S)-salbutamol to poor asthma control further enantioselective investigations are warranted in severe asthma.
Asunto(s)
Albuterol/sangre , Asma/tratamiento farmacológico , Broncodilatadores/sangre , Estado Asmático/sangre , Administración por Inhalación , Adulto , Albuterol/química , Albuterol/uso terapéutico , Asma/sangre , Broncodilatadores/química , Broncodilatadores/uso terapéutico , Relación Dosis-Respuesta a Droga , Femenino , Humanos , Modelos Lineales , Masculino , Proyectos Piloto , EstereoisomerismoRESUMEN
OBJECTIVE: To evaluate our clinical experience with the use of non-invasive mechanical ventilation (NIMV) in patients with an acute asthmatic attack. DESIGN: Seven-year period retrospective observational study. SETTING: General intensive care department (ICU) of a county hospital. PATIENTS: From 1992 to 1998, we documented clinical data, gas exchange and outcome of every asthmatic patient admitted to our ICU because of status asthmaticus (SA) refractory to initial medical therapy. INTERVENTIONS: Clinical charts were reviewed and patients were allocated to two groups according to their suitability as participants in an NIMV trial. Patients who arrived in respiratory arrest and those who ultimately improved with medical management alone were not considered candidates for NIMV. For the present analysis, the rest of the patients were considered candidates for NIMV, while the decision to start a NIMV trial or to perform endotracheal intubation (ETI) remained at the discretion of the attending physician. When patients failed to improve with NIMV, standard mechanical ventilation (MV) with ETI was initiated. MEASUREMENTS AND RESULTS: Fifty-eight patients were included in the study. Twenty-five patients (43%) were not eligible for NIMV: 11 patients (19%) because of respiratory arrest on their arrival at the Emergency Room and 14 patients (24%) because of improvement with medical management (bronchodilators, corticoids and oxygen). The remaining 33 patients were eligible for NIMV (57%): 11 patients (33%) received invasive MV and 22 patients (67%) were treated with NIMV. Three NIMV patients (14%) needed ETI. We compared data at baseline, 30 min, 2-6 h and 6-12 h after the onset of ventilatory support. Significant differences were observed in arterial blood gases on admission to the Emergency Room between MV and NIMV: PaCO2 (89 +/- 29 mmHg vs 53 +/- 13 mmHg, p < 0.05), pH (7.05 +/- 0.21 vs 7.28 +/- 0.008, p < 0.05) and HCO3- level (22 +/- 5 mmol/l vs 26 +/- 6 mmol/l, p < 0.05). No differences were found in the median length of ICU stay (4.5 vs 3 days), median hospital stay (15 vs 12 days) and mortality (0 vs 4%). CONCLUSION: Face mask NIMV appears to be a suitable method for improving alveolar ventilation and can reduce the need for intubation in a selected group of patients with SA.
Asunto(s)
Máscaras , Respiración Artificial/instrumentación , Respiración Artificial/métodos , Estado Asmático/terapia , Enfermedad Aguda , Anciano , Análisis de los Gases de la Sangre , Cuidados Críticos/métodos , Tratamiento de Urgencia/métodos , Femenino , Mortalidad Hospitalaria , Humanos , Unidades de Cuidados Intensivos/estadística & datos numéricos , Intubación Intratraqueal , Tiempo de Internación/estadística & datos numéricos , Tiempo de Internación/tendencias , Masculino , Persona de Mediana Edad , Admisión del Paciente/estadística & datos numéricos , Admisión del Paciente/tendencias , Selección de Paciente , Intercambio Gaseoso Pulmonar , Respiración Artificial/efectos adversos , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Estado Asmático/sangre , Estado Asmático/mortalidad , Factores de Tiempo , Resultado del TratamientoRESUMEN
OBJECTIVE: To determine, if possible, whether magnesium deficiency exists in children with asthma during acute attacks and between exacerbations. SETTING: Emergency Department Clinic and Outpatient Pediatric Clinic of Jordan University of Science and Technology, Irbid. METHODS: A total of 174 known asthmatic children who presented to the emergency department in acute attack (group 1) and 94 asthmatic children who presented to outpatient clinics for follow-up of asthma (group 2) had their serum magnesium levels assayed and compared with 232 patients without asthma (controls; group 3). Exclusion criteria were history of renal disease, cardiac disease, malabsorption, diuretic use, alcoholism, and pregnancy. RESULTS: There were no differences between study groups, although male patients had a slightly lower level of magnesium than female patients. CONCLUSION: After removing the confounder of sex, serum magnesium levels in asthmatic children during acute attacks and between exacerbations are not significantly different from those of controls.
Asunto(s)
Asma/sangre , Magnesio/sangre , Asma/tratamiento farmacológico , Niño , Humanos , Modelos Lineales , Magnesio/uso terapéutico , Análisis Multivariante , Índice de Severidad de la Enfermedad , Factores Sexuales , Estado Asmático/sangreRESUMEN
Serum eosinophil cationic protein (sECP) levels were measured in 339 patients with childhood asthma, and the clinical courses of these patients were followed for 57 weeks. While considering the history and characteristics of each patient, we examined the correlation between asthma attack frequency and sECP, blood eosinophil count, and serum total IgE (tIgE) to determine their usefulness in predicting asthma attacks. Among patients with no other allergic diseases, sECP levels in patients who had no asthma attacks two weeks before or after the measurement were significantly lower than those of patients who had attacks during the same four-week period. Among patients who had attacks, those patients with no attack for a year after the measurement were also found to have low sECP levels. Similarly, even among patients with asthma attacks and high sECP levels, there were cases where attacks were well controlled using nebulizer treatments with DSCG or BDP. The incident rate of attacks for patients with other allergic diseases and a low sECP was low. Yet, there was no common trend in patients with high sECP levels. Moreover, this study detected a significant correlation between sECP level and blood eosinophil count as well as between sECP level and serum tIgE. The most significant correlation with asthma attack frequency was sECP level. Thus, sECP level seems to reflect the allergy activity level, especially two weeks prior to and after the measurement. For patients without other allergic diseases, asthma attack prediction during the two weeks period after the measurement of sECP also seems possible. Therefore, periodic measurement of sECP level is useful in objectively monitoring the improvement of symptoms and establishing the treatment plan, including treatment with DSCG or BDP.
Asunto(s)
Asma/sangre , Proteínas Sanguíneas/análisis , Ribonucleasas , Estado Asmático/sangre , Adolescente , Asma/inmunología , Niño , Preescolar , Proteínas en los Gránulos del Eosinófilo , Eosinófilos , Femenino , Humanos , Inmunoglobulina E/sangre , Lactante , Recuento de Leucocitos , MasculinoRESUMEN
Estudio prospectivo, longitudinal, observacional, comparativo, en 50 niños de uno y otro sexo (30 masculino y 20 femeninos), con edades entre 6 y 18 años, con crisis asmática moderada. Se determinó la saturación arterial de oxigeno (SaO2) y el flujo espiratorio máximo (FFM) al momento de su llegada a urgencias y a los 30 minutos, 2, 4 y 24 horas después de la administración de salbutamol en aerosol (100 mcg/dosis), con el propósito de relacionar el valor de ambas mediciones con el pronóstico de dichos pacientes. De los 50 pacientes evaluados 48 se trataron en forma ambulatoria y dos requirieron hospitalización. Se observaron diferencias estadisticamente significativas en la SaO2, basal y los registros tomados a las 2, 4 y 24 horas postratamiento (p < 0.01), y sólo se observaron diferencias estadisticamente significativas entre el FEM basal y el registro tomado a las 24 horas postratamiento. En conclusión la SaO2 tiene un mejor valor predictivo que el FEM en la evolución de la crisis asmática en niños
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Albuterol/farmacología , Albuterol/uso terapéutico , Estudios de Cohortes , Estado Asmático/fisiopatología , Estado Asmático/tratamiento farmacológico , Estado Asmático/sangre , Estado Asmático/epidemiología , Flujo Espiratorio Máximo/efectos de los fármacos , Oxígeno/sangre , Presión Parcial , Valor Predictivo de las PruebasRESUMEN
Se midieron la quimiocinesis y quimiotaxis en células polimorfonucleares (PMN) obtenidas de 51 niños de 1 a 8 años de edad, de uno y otro sexo. Grupo de casos: 41 niños con asma no alérgica e infecciones crónicas recurrentes de las vías aéreas superiores; los criterios diagnósticos fueron antecedentes de sibilancias relacionadas con un episodio de infección de las vías aéreas superiores y pruebas cutáneas negativas. Grupo testigo: 10 niños sanos. Se obtuvo una muestra de 10 ml de sangre venosa periférica. Los PMN se incubaron con solución de Hank para medir la quimiocinesis y con C5a y extracto de Staphylococcus aureus para medir quimiotaxis. Los valores de quimiocinesis en los niños sanos testigos y en los pacientes con asma bronquial no alérgica fueron de 46.0 ñ 7.1 vs 23.8 ñ 6.1 µm (p < 0.01). Los valores de quimiotaxis estimulada con C5a en los niños sanos testigos y en los pacientes con asma bronquial no alérgica fueron de 91.0 ñ 21.3 vs 92.3 ñ 21.0 µm (ns), y los valores de quimiotaxis estimulada con extracto de Staphylococcus aureus fueron de 97.0 ñ 22.4 vs 92.0 ñ 23.0 µm (ns). Estos resultados sugieren que los PMN de niños con asma no atópica tienen quimiocinesis reducida. Después de un estímulo quimiotáctico con C5a y extracto bacteriano, la movilidad de los leucocitos se corige y alcanza valores similares a los coexistentes en niños sanos
Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Quimiotaxis de Leucocito/efectos de los fármacos , Enfermedad Crónica , Estado Asmático/inmunología , Estado Asmático/sangre , Neutrófilos , Recurrencia , Infecciones del Sistema Respiratorio/sangre , Infecciones del Sistema Respiratorio/inmunología , Staphylococcus aureus/inmunologíaRESUMEN
OBJECTIVES: To assess the effects of breathing a low-density gas mixture on dyspnea and the pulsus paradoxus in children with status asthmaticus. DESIGN: In an urban academic tertiary referral center, 18 patients, aged 16 months to 16 years, who were being treated for status asthmaticus with continuously inhaled beta-agonist and intravenously administered methylprednisolone and had a pulsus paradoxus of greater than 15 mm Hg received either an 80%:20% helium-oxygen gas mixture (HELIOX patients) or room air (control patients) at 10 L/min by nonrebreathing face mask in a double-blind, randomized, controlled trial. In all patients, baseline data, including pulsus paradoxus (determined by sphygmomanometer or arterial catheter blood pressure readings), respiratory rate, heart rate, investigator-scored dyspnea index, and oxygen saturation, were compared with values obtained 15 minutes during and after intervention. In a subset of patients, peak flows before and after breathing HELIOX or room air were measured. When clinically indicated, arterial blood gases were obtained. RESULTS: The pulsus paradoxus (in millimeters of mercury) fell significantly from an initial mean value of 23.3 +/- 6.8 to 10.6 +/- 2.8 with HELIOX breathing (p < 0.001) and increased again to 18.5 +/- 7.3 after cessation of HELIOX. Peak flow increased 69.4% +/- 12.8% during HELIOX breathing (p < 0.05). The dyspnea index decreased from an initial mean value of 5.7 +/- 1.3 to 1.9 +/- 1.7 with HELIOX breathing (p < 0.0002) and increased again to 4.0 +/- 0.5 after cessation of HELIOX breathing. In control patients, there was no significant difference in pulsus paradoxus or dyspnea index at any time during the study period. Mechanical ventilation was averted in three patients in whom dyspnea lessened dramatically during breathing of HELIOX. CONCLUSION: During acute status asthmaticus, inhaled HELIOX significantly lowered the pulsus paradoxus, increased peak flow, and lessened the dyspnea index. Moreover, HELIOX spared three patients a planned intubation and caused no apparent side effects. Thus HELIOX reduces the work of breathing and may forestall respiratory failure in children with status asthmaticus, thus preventing the need for mechanical ventilation.
Asunto(s)
Helio/administración & dosificación , Oxígeno/administración & dosificación , Estado Asmático/tratamiento farmacológico , Administración por Inhalación , Adolescente , Análisis de Varianza , Niño , Preescolar , Método Doble Ciego , Femenino , Humanos , Lactante , Masculino , Pulso Arterial/efectos de los fármacos , Estadísticas no Paramétricas , Estado Asmático/sangre , Estado Asmático/fisiopatología , Trabajo Respiratorio/efectos de los fármacosRESUMEN
Asthmatic crisis is one of the most frequent urgencies in children. One of the most difficult decision for a physician is to determine what patient requires only ambulatory treatment and what patient needs hospital treatment. Many investigators have developed predictive scores, but to date conclusions are confusing. The purpose of the present study was to compare the value of arterial oxygen saturation versus peak expiratory flow rate measurements as predictors of the outcome of the asthmatic crisis in children. We performed a prospective, longitudinal, observational, comparative study in 50 children (30 males, 20 female), with ages between 6 and 18 years old, with the presence of a moderate asthmatic crisis. We measured arterial oxygen saturation and peak expiratory flow rate at the moment of their arrival to urgencies and at 30 minutes, 2, 4 and 24 hours after the administration of nebulized albuterol (100 mcg/k/dose). We found significant differences on baseline arterial oxygen saturation and the registrations taken at 2, 4, and 24 hours posttreatment (0.01), and we could only find significant differences between baseline peak expiratory flow rate and the registrations taken at 24 hours pretreatment. In conclusion arterial oxygen saturation is a better predictor than peak expiratory flow rate in the evolution of the asthmatic crisis in children.